Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 0 | 500 | 0 | 0 |
| Gross Profit | N/A | N/A | 500 | N/A | N/A |
| Operating Expenses | 12,699 | 11,593 | 7,261 | 4,519 | 2,482 |
| Operating Income | -12,699 | -11,593 | -6,761 | -4,519 | -2,482 |
| Other Income | 434 | 975 | 1,107 | 259 | 281 |
| Pre-tax Income | -12,265 | -10,618 | -5,654 | -4,260 | -2,201 |
| Income Tax | 27 | 31 | 80 | 0 | 22 |
| Net Income Continuous | -12,292 | -10,649 | -5,734 | -4,260 | -2,223 |
| Net Income | $-12,292 | $-10,649 | $-5,734 | $-4,260 | $-2,223 |
| EPS Basic Total Ops | -0.78 | -0.89 | -0.74 | -0.72 | -0.40 |
| EPS Basic Continuous Ops | -0.78 | -0.89 | -0.74 | -0.72 | -0.47 |
| EPS Diluted Total Ops | -0.78 | -0.89 | -0.74 | -0.72 | -0.40 |
| EPS Diluted Continuous Ops | -0.78 | -0.89 | -0.74 | -0.72 | -0.47 |
| EPS Diluted Before Non-Recurring Items | -0.78 | -0.89 | N/A | N/A | N/A |
| EBITDA(a) | $-12,682 | $-11,646 | $-6,746 | $-4,515 | $-2,479 |